TY - JOUR
T1 - Major depression, physical health and molecular senescence markers abnormalities
AU - Seitz-Holland, Johanna
AU - Mulsant, Benoit H.
AU - Reynolds, Charles F.
AU - Blumberger, Daniel M.
AU - Karp, Jordan F.
AU - Butters, Meryl A.
AU - Mendes-Silva, Ana Paula
AU - Vieira, Erica L.
AU - Tseng, George
AU - Lenze, Eric J.
AU - Diniz, Breno S.
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2023/3
Y1 - 2023/3
N2 - Previous studies suggested the role of cellular senescence in late-life depression (LLD). However, it is unclear how this finding relates to common features of LLD, such as medical and cognitive problems. We applied factor analyses to an extensive battery of clinical variables in 426 individuals with LLD. Here we tested the relationship between these factors, age and sex, with an index of cellular senescence based on 22 senescence-associated secretory phenotype proteins. We found four factors: ‘depression and anxiety severity’, ‘cognitive functioning’, ‘cardiovascular and cardiometabolic health’ and ‘blood pressure’. A higher senescence-associated secretory phenotype index was associated with poorer ‘cognitive functioning’ and ‘cardiovascular and cardiometabolic health’ but not with ‘depression and anxiety severity’. These findings highlight the role of cellular senescence in poorer physical and cognitive health in LLD. They are consonant with the viewpoint that co-occurring medical burdens and their associated disabilities are part of a phenotype of accelerated ageing in LLD.
AB - Previous studies suggested the role of cellular senescence in late-life depression (LLD). However, it is unclear how this finding relates to common features of LLD, such as medical and cognitive problems. We applied factor analyses to an extensive battery of clinical variables in 426 individuals with LLD. Here we tested the relationship between these factors, age and sex, with an index of cellular senescence based on 22 senescence-associated secretory phenotype proteins. We found four factors: ‘depression and anxiety severity’, ‘cognitive functioning’, ‘cardiovascular and cardiometabolic health’ and ‘blood pressure’. A higher senescence-associated secretory phenotype index was associated with poorer ‘cognitive functioning’ and ‘cardiovascular and cardiometabolic health’ but not with ‘depression and anxiety severity’. These findings highlight the role of cellular senescence in poorer physical and cognitive health in LLD. They are consonant with the viewpoint that co-occurring medical burdens and their associated disabilities are part of a phenotype of accelerated ageing in LLD.
UR - https://www.scopus.com/pages/publications/85165801469
U2 - 10.1038/s44220-023-00033-z
DO - 10.1038/s44220-023-00033-z
M3 - Article
AN - SCOPUS:85165801469
SN - 2731-6076
VL - 1
SP - 200
EP - 209
JO - Nature Mental Health
JF - Nature Mental Health
IS - 3
M1 - 5495
ER -